{"id":"https://openalex.org/W4283330334","doi":"https://doi.org/10.1016/j.ajoc.2022.101631","title":"Delayed onset anterior uveitis and macular edema after cessation of pembrolizumab","display_name":"Delayed onset anterior uveitis and macular edema after cessation of pembrolizumab","publication_year":2022,"publication_date":"2022-06-22","ids":{"openalex":"https://openalex.org/W4283330334","doi":"https://doi.org/10.1016/j.ajoc.2022.101631","pmid":"https://pubmed.ncbi.nlm.nih.gov/35774195","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9237938"},"language":"en","primary_location":{"id":"doi:10.1016/j.ajoc.2022.101631","doi":"https://doi.org/10.1016/j.ajoc.2022.101631","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ajoc.2022.101631","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2451993622003772/pdf","source":{"id":"https://openalex.org/S2765008417","display_name":"American Journal of Ophthalmology Case Reports","issn_l":"2451-9936","issn":["2451-9936"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Ophthalmology Case Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S2451993622003772/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018721779","display_name":"Mauranda Men","orcid":"https://orcid.org/0000-0002-0237-903X","observed_orcids":["https://orcid.org/0000-0002-0237-903X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mauranda Men","raw_affiliation_strings":["David Geffen School of Medicine at UCLA, Los Angeles, CA, USA"],"raw_orcid":"https://orcid.org/0000-0002-0237-903X","affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at UCLA, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020292429","display_name":"Edmund Yik Kong Tsui","orcid":"https://orcid.org/0000-0001-7532-9191","observed_orcids":["https://orcid.org/0000-0001-7532-9191"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Edmund Tsui","raw_affiliation_strings":["Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA"],"raw_orcid":"https://orcid.org/0000-0001-7532-9191","affiliations":[{"raw_affiliation_string":"Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5020292429"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":1030,"currency":"USD","value_usd":1030},"apc_paid":{"value":1030,"currency":"USD","value_usd":1030},"fwci":0.8065,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.71068255,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"27","issue":null,"first_page":"101631","last_page":"101631"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6338000297546387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6338000297546387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.2930000126361847,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.06199999898672104,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anterior-uveitis","display_name":"anterior uveitis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/macular-edema","display_name":"macular edema","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.972000002861023},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9169999957084656},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9300000071525574},{"id":"https://openalex.org/keywords/belzutifan","display_name":"belzutifan","score":0.8579999804496765},{"id":"https://openalex.org/keywords/lenvatinib","display_name":"lenvatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/axitinib","display_name":"axitinib","score":0.8659999966621399},{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":0.8569999933242798},{"id":"https://openalex.org/keywords/difluprednate","display_name":"difluprednate","score":0.9160000085830688},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9664638042449951},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8968418836593628},{"id":"https://openalex.org/C2776194053","wikidata":"https://www.wikidata.org/wiki/Q280027","display_name":"Uveitis","level":2,"score":0.6907387971878052},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5784977078437805},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47325044870376587},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.43449363112449646},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.4309341311454773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3465646505355835},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3426121473312378},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3278709053993225},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.30825328826904297},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29758039116859436},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.22305116057395935},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.15273532271385193}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.ajoc.2022.101631","doi":"https://doi.org/10.1016/j.ajoc.2022.101631","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ajoc.2022.101631","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2451993622003772/pdf","source":{"id":"https://openalex.org/S2765008417","display_name":"American Journal of Ophthalmology Case Reports","issn_l":"2451-9936","issn":["2451-9936"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Ophthalmology Case Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9237938","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9237938","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am J Ophthalmol Case Rep","raw_type":"Text"},{"id":"pmid:35774195","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35774195","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of ophthalmology case reports","raw_type":"Case Reports"},{"id":"pmh:oai:doaj.org/article:25b69e9e46bc40dabd569788907598a5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/25b69e9e46bc40dabd569788907598a5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Journal of Ophthalmology Case Reports, Vol 27, Iss , Pp 101631- (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.ajoc.2022.101631","doi":"https://doi.org/10.1016/j.ajoc.2022.101631","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ajoc.2022.101631","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2451993622003772/pdf","source":{"id":"https://openalex.org/S2765008417","display_name":"American Journal of Ophthalmology Case Reports","issn_l":"2451-9936","issn":["2451-9936"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Ophthalmology Case Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306811","display_name":"Research to Prevent Blindness","ror":"https://ror.org/04drjs621"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283330334.pdf","grobid_xml":"https://content.openalex.org/works/W4283330334.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W2058004519","https://openalex.org/W2783137027","https://openalex.org/W2904424259","https://openalex.org/W2913006918","https://openalex.org/W2918950605","https://openalex.org/W2950848761","https://openalex.org/W2956028371","https://openalex.org/W2973451075","https://openalex.org/W3047018443","https://openalex.org/W3081450329","https://openalex.org/W3093827958","https://openalex.org/W3148902978","https://openalex.org/W3202386483","https://openalex.org/W4206629637","https://openalex.org/W4210370153"],"related_works":["https://openalex.org/W4360608771","https://openalex.org/W4313561458","https://openalex.org/W2807248161","https://openalex.org/W2991201958","https://openalex.org/W2912748007","https://openalex.org/W2995434251","https://openalex.org/W2201460159","https://openalex.org/W3046736595","https://openalex.org/W3101801778","https://openalex.org/W4302283132"],"abstract_inverted_index":{"Purpose:":[0],"To":[1],"report":[2],"a":[3,28],"case":[4],"of":[5,17,30,41,100,133],"macular":[6,43],"edema":[7,44],"and":[8,45,55,68,89,94,103],"anterior":[9,46],"uveitis":[10],"that":[11],"developed":[12],"5":[13],"months":[14,72,77,117],"after":[15,118],"discontinuation":[16],"pembrolizumab,":[18],"an":[19],"immune":[20,111,134],"checkpoint":[21,112,135],"inhibitor.":[22],"Observations:":[23],"A":[24],"67-year-old":[25],"man":[26],"with":[27,97],"history":[29],"metastatic":[31],"clear":[32],"cell":[33,35],"renal":[34],"carcinoma":[36],"was":[37],"referred":[38],"for":[39,70,125],"evaluation":[40],"bilateral":[42],"uveitis,":[47],"potentially":[48],"attributed":[49],"to":[50,80,110,127],"his":[51,92],"recently":[52],"initiated":[53],"belzutifan":[54,93],"lenvatinib":[56,95],"chemotherapy":[57],"regimen.":[58],"Upon":[59],"further":[60],"review,":[61],"he":[62,90],"had":[63,74],"previously":[64],"been":[65],"on":[66,85],"pembrolizumab":[67],"axitinib":[69],"20":[71],"but":[73],"stopped":[75],"five":[76],"prior":[78],"due":[79],"cancer":[81],"progression.":[82],"Symptoms":[83],"resolved":[84],"difluprednate":[86],"0.05%":[87],"drops,":[88],"restarted":[91],"treatment":[96],"no":[98],"recurrence":[99],"uveitis.":[101],"Conclusion":[102],"Importance:":[104],"Ocular":[105],"immune-related":[106,131],"adverse":[107],"events":[108],"secondary":[109],"inhibitor":[113],"therapy":[114],"can":[115],"occur":[116],"stopping":[119],"the":[120,129],"medication.":[121],"It":[122],"is":[123],"important":[124],"clinicians":[126],"recognize":[128],"delayed":[130],"effects":[132],"inhibitors.":[136]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2022-06-24T00:00:00"}